Stock CTE CRYOSITE LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

Financials Cryosite Limited

Equities

CTE

AU000000CTE1

Healthcare Facilities & Services

Delayed Australian S.E.
Other stock markets
 08:02:29 2024-04-29 pm EDT 		5-day change 1st Jan Change
0.85 AUD -.--% Intraday chart for Cryosite Limited +4.94% +40.50%
Feb. 22 Cryosite Limited Announces Board Changes CI
Feb. 22 Cryosite Limited Reports Earnings Results for the Half Year Ended December 31, 2023 CI

Valuation

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Capitalization 1 4.217 2.343 6.092 18.74 30.75 30.51
Enterprise Value (EV) 1 -0.4707 -1.901 3.292 15.93 26.26 27.38
P/E ratio -3.4 x -1.36 x 4.29 x 29.9 x 22.6 x 21.7 x
Yield - - - - 1.59% 2.4%
Capitalization / Revenue 0.72 x 0.3 x 0.68 x 1.87 x 2.62 x 2.56 x
EV / Revenue -0.08 x -0.24 x 0.37 x 1.59 x 2.23 x 2.29 x
EV / EBITDA -0.78 x -8.56 x 3.65 x 11.4 x 12 x 14.1 x
EV / FCF -0.94 x -0.88 x -7.76 x 38.4 x 17.3 x 29.1 x
FCF Yield -107% -113% -12.9% 2.61% 5.77% 3.44%
Price to Book 2.17 x -1.37 x -21.2 x 49.7 x 16.5 x 11 x
Nbr of stocks (in thousands) 46,860 46,860 46,860 46,860 48,810 48,810
Reference price 2 0.0900 0.0500 0.1300 0.4000 0.6300 0.6250
Announcement Date 8/29/18 8/21/19 8/27/20 8/24/21 8/25/22 8/24/23
1AUD in Million2AUD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net sales 1 5.864 7.912 8.92 10.02 11.76 11.94
EBITDA 1 0.6029 0.2221 0.9027 1.392 2.189 1.945
EBIT 1 0.2594 -0.0189 0.7122 1.062 1.892 1.524
Operating Margin 4.42% -0.24% 7.98% 10.6% 16.09% 12.77%
Earnings before Tax (EBT) 1 0.1489 -1.446 1.766 1.12 1.806 1.575
Net income 1 -1.24 -1.723 1.48 0.6526 1.364 1.409
Net margin -21.15% -21.77% 16.59% 6.51% 11.6% 11.81%
EPS 2 -0.0265 -0.0368 0.0303 0.0134 0.0279 0.0289
Free Cash Flow 1 0.5014 2.149 -0.4243 0.415 1.515 0.9419
FCF margin 8.55% 27.17% -4.76% 4.14% 12.88% 7.89%
FCF Conversion (EBITDA) 83.16% 967.72% - 29.81% 69.19% 48.43%
FCF Conversion (Net income) - - - 63.59% 111.06% 66.85%
Dividend per Share - - - - 0.0100 0.0150
Announcement Date 8/29/18 8/21/19 8/27/20 8/24/21 8/25/22 8/24/23
1AUD in Million2AUD
Estimates

Balance Sheet Analysis

Fiscal Period: June 2018 2019 2020 2021 2022 2023
Net Debt 1 - - - - - -
Net Cash position 1 4.69 4.24 2.8 2.82 4.49 3.13
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 0.5 2.15 -0.42 0.41 1.51 0.94
ROE (net income / shareholders' equity) -9.61% -1,515% -148% 1,438% 122% 60.7%
ROA (Net income/ Total Assets) 1.85% -0.08% 1.91% 2.92% 5.44% 4.31%
Assets 1 -67.21 2,255 77.61 22.36 25.08 32.66
Book Value Per Share 2 0.0400 -0.0400 -0.0100 0.0100 0.0400 0.0600
Cash Flow per Share 2 0.1000 0.0800 0.0900 0.0800 0.1100 0.1000
Capex 1 0.18 0.03 0.89 0.4 0.86 0.3
Capex / Sales 3.08% 0.33% 9.97% 3.96% 7.34% 2.52%
Announcement Date 8/29/18 8/21/19 8/27/20 8/24/21 8/25/22 8/24/23
1AUD in Million2AUD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Annual profits - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
CRYOSITE LIMITED Stock Cryosite Limited
+40.50% 27.21M
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.25% 85.02B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+14.46% 82.37B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+9.37% 29.29B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-11.40% 17.21B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-0.36% 16.7B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
+0.22% 15.5B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
+4.32% 12.15B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-2.34% 12.13B
DAVITA INC. Stock DaVita Inc.
+32.69% 12.12B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. CTE Stock
  4. Financials Cryosite Limited